|
|
EPMedSystems, Inc. (EPMD) |
|
|
CEOCFO CEOCFO Monthly Analyst |
"To print this page go to file and left click on print" EPMedSystems,
Inc. is continually evolving to meet the needs of electrophysiologist in a
laboratory-based instrumentation setting CEOCFOinterviews: Dr.
Saksena, please tell us about your background and medical practice. CEOCFOinterviews: Can you tell us about your relationship with EPMedSystems? Dr. Saksena: “We have had the opportunity to work with EPMedSystems, Inc. (NASD: EPMD) on a variety of their products. We have their current WorkMateâ recording system and work with a variety of their commercially approved and investigational catheter products. We also have done clinical investigation with their different defibrillation systems for atrial fibrillation.” CEOCFOinterviews: What do you find about their products that makes them perhaps better than others out there? Dr. Saksena: “I
think that EPMedSystems have continually evolved to meeting the needs of the
electrophysiologist in a specific setting, which is a laboratory-based instrumentation
setting. Their focus has been fairly clear and well defined. They have, from the
beginning, been involved in both catheter recording and signal processing systems for the
laboratory. In addition, they have refined their products while maintaining that focus. I
think their new product line is highly competitive in the area of recording systems. CEOCFOinterviews: Have they developed systems to your needs and provided the necessary support? Dr. Saksena: “I have had a long-standing involvement with their research and clinical areas. They have developed systems to our needs. I think they have expanded their service force recently and that is one of the challenges for a medium-sized company when they start growing, which is to have enough trained support people. I think they are trying to meet that challenge at this point.” CEOCFOinterviews: It sounds like you think EPMedSystems is ahead of the curve and the industry. Dr. Saksena: “In certain areas, they clearly are and very competitive in other areas. The EP laboratory is becoming increasingly a therapeutic laboratory and not just a diagnostic laboratory; the diagnostic work may have reached a plateau. Therefore, I think that EPMedSystems is well positioned to take advantage of the growth in the therapeutic laboratory part of this industry.” CEOCFOinterviews: What are your thoughts on the CEO of EPMedSystems? Dr. Saksena: “I think EPMedSystems has taken some important organizational steps. Many of these companies start with dedicated technical and clinical leaders who drive the process and at some point get transitioned into a business development expansion, where they get management that is well trained in business practices, and yet try to retain there technical expertise. I think EPMedSystems has just made that transition with the hiring of CEO, Reinhard Schmidt.” disclaimers |
